Traquilan en es it fr

Traquilan Brand names, Traquilan Analogs

Traquilan Brand Names Mixture

  • No information avaliable

Traquilan Chemical_Formula

C18H18ClNS

Traquilan RX_link

No information avaliable

Traquilan fda sheet

Traquilan msds (material safety sheet)

Traquilan MSDS

Traquilan Synthesis Reference

No information avaliable

Traquilan Molecular Weight

315.861 g/mol

Traquilan Melting Point

97.5 oC

Traquilan H2O Solubility

0.295 mg/L

Traquilan State

Solid

Traquilan LogP

5.654

Traquilan Dosage Forms

Tablets; Syrup (concentrate)

Traquilan Indication

For treatment of psychotic disorders (e.g. schizophrenia) and of acute mania occuring as part of bipolar disorders.

Traquilan Pharmacology

Chlorprothixene is a typical antipsychotic drug of the thioxanthine class. It has a low antipsychotic potency (half to 2/3 of chlorpromazine). An intrinsic antidepressant effect of chlorprothixene has been discussed, but not proven yet. Likewise, it is unclear, if chlorprothixene has genuine analgesic effects. An antiemetic effect, as with most antipsychotics, exists. It is used in the treatment of nervous, mental, and emotional conditions. Improvement in such conditions is thought to result from the effect of the medicine on nerve pathways in specific areas of the brain. Chlorprothixene has a strong sedative activity with a high incidence of anticholinergic side-effects. Chlorprothixene is structurally related to chlorpromazine, with which it shares in principal all side effects. Allergic side-effects and liver damage seem to appear with an appreciable lower frequency.

Traquilan Absorption

No information avaliable

Traquilan side effects and Toxicity

Symptoms of overdose include difficulty in breathing (severe), dizziness (severe), drowsiness (severe), muscle trembling, jerking, stiffness, or uncontrolled movements (severe), small pupils, unusual excitement, and unusual tiredness or weakness (severe).

Traquilan Patient Information

Traquilan Organisms Affected

Humans and other mammals